Ciprofloxacin usage and bacterial resistance patterns in Crohn's disease patients with abscesses

Journal of Clinical Gastroenterology

Volumn 48, Issue 8, 2014, Pages 703-707

  Park, Soo Kyung ^a   Kim, Kyung Jo ^a   Lee, Sang Oh ^a   Yang, Dong Hoon ^a   Jung, Kee Wook ^a   Duk Ye, Byong ^a   Byeon, Jeong Sik ^a   Myung, Seung Jae ^a   Yang, Suk Kyun ^a   Kim, Jin Ho ^a   Yu, Chang Sik ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

abscess; ciprofloxacin; Crohn's disease

Indexed keywords

CEPHALOSPORIN; CIPROFLOXACIN; CORTICOSTEROID; METRONIDAZOLE; ANTIINFECTIVE AGENT;

ABDOMINAL ABSCESS; ABSCESS DRAINAGE; ADULT; ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIOLOGY; BACTERIUM CULTURE; COMPUTER ASSISTED TOMOGRAPHY; CROHN DISEASE; DEMOGRAPHY; DISEASE DURATION; ESCHERICHIA COLI; HOSPITALIZATION; HUMAN; INFLAMMATORY BOWEL DISEASE; KRUSKAL WALLIS TEST; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS DRAINAGE; PRIORITY JOURNAL; TERTIARY CARE CENTER; TREATMENT OUTCOME; ADOLESCENT; COMPLICATION; DRAINAGE; FEMALE; LENGTH OF STAY; MICROBIOLOGY; MIDDLE AGED; PROCEDURES; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ABDOMINAL ABSCESS; ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CIPROFLOXACIN; CROHN DISEASE; DRAINAGE; DRUG RESISTANCE, BACTERIAL; FEMALE; HOSPITALIZATION; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84905991378     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0000000000000024     Document Type: Article

References (22)

1. Keighley MR, Eastwood D, Ambrose NS, et al. Incidence and microbiology of abdominal and pelvic abscess in Crohn's disease. Gastroenterology. 1982;83:1271-1275. (Pubitemid 13235929)
2. Garcia JC, Persky SE, Bonis PA, et al. Abscesses in Crohn's disease: outcome of medical versus surgical treatment. J Clin Gastroenterol. 2001;32:409-412. (Pubitemid 32378273)
3. Lee H, Kim YH, Kim JH, et al. Nonsurgical treatment of abdominal or pelvic abscess in consecutive patients with Crohn's disease. Dig Liver Dis. 2006;38:659-664. (Pubitemid 44356257)
4. Gervais DA, Hahn PF, O'Neill MJ, et al. Percutaneous abscess drainage in Crohn disease: technical success and short-and long-term outcomes during 14 years. Radiology. 2002;222: 645-651. (Pubitemid 34215208)
5. Wang SL, Wang ZR, Yang CQ. Meta-analysis of broad-spectrum antibiotic therapy in patients with active inflammatory bowel disease. Exp Ther Med. 2012;4:1051-1056.
6. Perencevich M, Burakoff R. Use of antibiotics in the treatment of inflammatory bowel disease. Inflamm Bowel Dis. 2006;12: 651-664. (Pubitemid 43977747)
7. Sartor RB. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology. 2004;126:1620-1633. (Pubitemid 38649878)
8. Falagas ME, Matthaiou DK, Bliziotis IA. Systematic review: fluoroquinolones for the treatment of intra-abdominal surgical infections. Aliment Pharmacol Ther. 2007;25:123-131. (Pubitemid 46046369)
9. Cullen G, Vaughn B, Ahmed A, et al. Abdominal phlegmons in Crohn's disease: outcomes following antitumor necrosis factor therapy. Inflamm Bowel Dis. 2012;18:691-696.
10. Yang SK, Yun S, Kim JH, et al. Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2005: a KASID study. Inflamm Bowel Dis. 2008;14:542-549. (Pubitemid 351571835)
11. Ye BD, Yang SK, Cho YK, et al. Clinical features and longterm prognosis of Crohn's disease in Korea. Scand J Gastro-enterol. 2010;45:1178-1185.
12. Feagins LA, Holubar SD, Kane SV, et al. Current strategies in the management of intra-abdominal abscesses in Crohn's disease. Clin Gastroenterol Hepatol. 2011;9:842-850.
13. Brook I. Microbiology and management of abdominal infections. Dig Dis Sci. 2008;53:2585-2591.
14. Brook I, Frazier EH. Aerobic and anaerobic microbiology in intra-abdominal infections associated with diverticulitis. J Med Microbiol. 2000;49:827-830. (Pubitemid 30666635)
15. Swidsinski A, Ladhoff A, Pernthaler A, et al. Mucosal flora in inflammatory bowel disease. Gastroenterology. 2002;122: 44-54. (Pubitemid 34049193)
16. Neut C, Bulois P, Desreumaux P, et al. Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn's disease. Am J Gastroenterol. 2002;97:939-946. (Pubitemid 34408252)
17. Darfeuille-Michaud A, Boudeau J, Bulois P, et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology. 2004;127: 412-421. (Pubitemid 39091889)
18. Ju HU, Lee HS, Kim JH, et al. Bacteriology, antibiotic susceptibility and empirical antibiotics of community-acquired perforated appendicitis. Infect Chemother. 2012;44: 439-445.
19. Fernandez J, Navasa M, Gomez J, et al. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology. 2002;35: 140-148. (Pubitemid 34032554)
20. Ortiz J, Vila MC, Soriano G, et al. Infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients. Hepatology. 1999;29:1064-1069. (Pubitemid 29168737)
21. Llovet JM, Rodriguez-Iglesias P, Moitinho E, et al. Spontaneous bacterial peritonitis in patients with cirrhosis undergoing selective intestinal decontamination. A retrospective study of 229 spontaneous bacterial peritonitis episodes. J Hepatol. 1997; 26:88-95. (Pubitemid 27072609)
22. Cholongitas E, Papatheodoridis GV, Lahanas A, et al. Increasing frequency of gram-positive bacteria in spontaneous bacterial peritonitis. Liver Int. 2005;25:57-61. (Pubitemid 40298245)